The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine
Open accessAbstract
Microdialysis in behaving animals was used to concomitantly characterize the dopamine and 5-HT responses in the caudate and the norepinephrine response in the hippocampus to the D- and L-isomers of amphetamine and methamphetamine. Doses of all four drugs which promoted similar stereotypy responses produced a D-amphetamine-like response profile of dopamine and dopamine metabolites, suggesting that all these drugs interact with dopamine systems to facilitate the release of transmitter. However, in contrast to the similar behavioral profiles, the magnitude of the dopamine responses diverged significantly. In addition, all four drugs increased extracellular norepinephrine and 5-HT, but the relative responses differed markedly from dopamine and from each other. The contrasting structure-activity relationships for these drugs likely reflect their differential potency at the various neuronal uptake transporters in promoting either transmitter release, and/or uptake blockade. In addition, the interaction of each drug at the vesicular transporters, as well as the availability of a cytoplasmic pool of transmitter likely also contribute to the neurotransmitter response. Because of the particularly divergent transmitter response profiles exhibited by L-methamphetamine, its behavioral and neurotransmitter effects were characterized over a more extended range of doses. Although the duration of the increase in extracellular dopamine was clearly proportional to dose, the dose-dependent increases in the magnitude of the dopamine response did not parallel the behavioral profiles. The results of these studies indicate that, while the dopamine, norepinephrine and 5-HT responses to these drugs probably contribute to the expression of stimulant-induced behaviors, simple relationships between the neurotransmitter responses and the behavioral profiles were not evident.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“AMP increases the synaptic levels of monoamines (dopamine, noradrenaline and serotonin) by increasing their release through a reversal of the monoamine transporters, primarily the catecholamine transporters (see Fleckenstein et al., 2007; Hutson et al., 2014, for review; Kuczenski et al., 1995; Sulzer et al., 2005).”
From Systematic reviews of the acute effects of amphetamine on working memory and other cognitive performances in healthy individuals, with a focus on the potential influence of personality traits (2023) · cites this paper as Kuczenski et al., 1995
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zetterström, T., Sharp, T., Marsden, C. A., & Ungerstedt, U. (1983) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1983.tb00893.x · Cited by 616
Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model.
Fischer, J. F., & Cho, A. K. (1979) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)31549-1 · Cited by 443
Self-citationDetermination of Brain Interstitial Concentrations by Microdialysis
Benveniste, H., Hansen, A. J., & Ottosen, N. S. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07252.x · Cited by 403
Kuczenski, R. T., & Segal, D. (1989) · Journal of Neuroscience · doi:10.1523/jneurosci.09-06-02051.1989 · Cited by 398
Self-citationSulzer, D., & Rayport, S. (1990) · Neuron · doi:10.1016/0896-6273(90)90339-h · Cited by 389
Heikkila, R. E., Orlansky, H., Mytilineou, C., & Cohen, G. (1975) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30227-2 · Cited by 220
Berger, U. V., Gu, X. F., & Azmitia, E. C. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90023-w · Cited by 199
Segal, D. S., & Kuczenski, R. (1987) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39192-5 · Cited by 177
Self-citationSampling considerations for on-line microbore liquid chromatography of brain dialysate
Wages, S. A., Church, W. H., & Justice, J. B. (1986) · Analytical Chemistry · doi:10.1021/ac00121a012 · Cited by 172
Globus, M. Y. ‐., Busto, R., Dietrich, W. D., Martinez, E., Valdés, I., & Ginsberg, M. D. (1989) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1989.123 · Cited by 165
Ståhle, L., Segersvärd, S., & Ungerstedt, U. (1991) · Journal of Pharmacological Methods · doi:10.1016/0160-5402(91)90021-v · Cited by 158
Kinetics and Block of Dopamine Uptake in Synaptosomes from Rat Caudate Nucleus
Krueger, B. K. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb08847.x · Cited by 155
d-Amphetamine as a releaser or reuptake inhibitor of biogenic amines in synaptosomes
Raiteri, M., Bertollini, A., Angelini, F., & Levi, G. (1975) · European Journal of Pharmacology · doi:10.1016/0014-2999(75)90239-3 · Cited by 146
Brain mechanisms of amphetamine-induced anorexia, locomotion, and stereotypy: A review
Cole, S. O. (1978) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(78)90050-7 · Cited by 140
Dynamic aspects of chromaffin granule structure
Phillips, J. H. (1982) · Neuroscience · doi:10.1016/0306-4522(82)90017-3 · Cited by 136
Zetterström, T., Sharp, T., & Ungerstedt, U. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90002-6 · Cited by 130
Rapid sampling and analysis of extracellular dopamine in vivo
Church, W. H., & Justice, J. B. (1987) · Analytical Chemistry · doi:10.1021/ac00132a007 · Cited by 130
Kalén, P., Strecker, R. E., Rosengren, E., & Björklund, A. (1989) · Brain Research · doi:10.1016/0006-8993(89)90901-3 · Cited by 128
Kuczenski, R. T., & Segal, D. S. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10903-8 · Cited by 126
Self-citationAbercrombie, E. D., & Zigmond, M. J. (1989) · Journal of Neuroscience · doi:10.1523/jneurosci.09-11-04062.1989 · Cited by 125
Florin, S. M., Kuczenski, R. T., & Segal, D. S. (1994) · Brain Research · doi:10.1016/0006-8993(94)91570-9 · Cited by 124
Self-citationIn vivo monoamine oxidase inhibition by d-amphetamine
Miller, H. H., Shore, P. A., & Clarke, D. E. (1980) · Biochemical Pharmacology · doi:10.1016/0006-2952(80)90429-3 · Cited by 120 · cited 1×
“It is unlikely that the decline in metabolites reflects AMPH inhibition of monoamine oxidase, since most evidence suggests that such an effect occurs only at relatively high AMPH concentrations (Green and El Hait, 1980; Miller et al., 1980).”
BackgroundKelly, P. H. (1977) · Springer eBooks · doi:10.1007/978-1-4684-3180-3_7 · Cited by 119
p-Chloroamphetamine induces serotonin release through serotonin transporters
Rudnick, G., & Wall, S. C. (1992) · Biochemistry · doi:10.1021/bi00144a010 · Cited by 102
Interactions of [3H]amphetamine with rat brain synaptosomes. II. Active transport.
Zaczek, R. C., Culp, S. G., & Souza, E. B. D. (1991) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24730-9 · Cited by 98
Effects of cathinone and amphetamine on the neurochemistry of dopamine in vivo
Pehek, E. A., Schechter, M., & Yamamoto, B. K. (1990) · Neuropharmacology · doi:10.1016/0028-3908(90)90041-o · Cited by 87
Kalén, P., Kokaia, M., Lindvall, O., & Björklund, A. (1988) · Brain Research · doi:10.1016/0006-8993(88)90454-4 · Cited by 78
Adell, A., Sarna, G. S., Hutson, P. H., & Curzon, G. (1989) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1989.tb11943.x · Cited by 77
Ferris, R. M., & Tang, F. L. M. (1979) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)31771-4 · Cited by 73
Sessions, G. R., Meyerhoff, J. L., Kant, G. J., & Koob, G. F. (1980) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(80)90195-1 · Cited by 66
Dopamine and noradrenaline transport into subcellular vesicles of the striatum
Philippu, A., & Beyer, J. (1973) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00501482 · Cited by 64
Callaway, C. W., Kuczenski, R. T., & Segal, D. S. (1989) · Brain Research · doi:10.1016/0006-8993(89)90118-2 · Cited by 64
Self-citationSabol, K. E., Richards, J. B., & Seiden, L. S. (1992) · Brain Research · doi:10.1016/0006-8993(92)91249-e · Cited by 61
Rutledge, C. O. (1978) · Biochemical Pharmacology · doi:10.1016/0006-2952(78)90386-6 · Cited by 51
Release of Catechol Amines from Isolated Medullary Granules by Sympathomimetic Amines
SCHÜMANN, H. J., & Philippu, A. (1962) · Nature · doi:10.1038/193890a0 · Cited by 49
Apomorphine Does Not Alter Amphetamine‐Induced Dopamine Release Measured in Striatal Dialysates
Kuczenski, R. T., Segal, D. S., & Manley, L. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb01196.x · Cited by 42
Self-citationvan Veldhuizen, M. J. A., Feenstra, M. G. P., Boer, G. J., & Westerink, B. H. C. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90841-v · Cited by 40
Johnson, R. G., Carty, S. E., Hayflick, S. J., & Scarpa, A. (1982) · Biochemical Pharmacology · doi:10.1016/0006-2952(82)90468-3 · Cited by 35
Green, A. L., & Hait, M. A. S. E. (1980) · Biochemical Pharmacology · doi:10.1016/0006-2952(80)90012-x · Cited by 33
Inhibition of norepinephrine transport into synaptic vesicles by amphetamine analogs.
Knepper, S. M., Grunewald, G. L., & Rutledge, C. O. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13390-9 · Cited by 30
Analysis of Impurities in Methamphetamine
Kishi, T., Inoue, T., SUZUKI, S., YASUDA, T., Oikawa, T., & Niwaguchi, T. (1983) · Eisei kagaku · doi:10.1248/jhs1956.29.6_400 · Cited by 27
Pei, Q., Zetterström, T., & Fillenz, M. (1989) · Neurochemistry International · doi:10.1016/0197-0186(89)90170-8 · Cited by 27
Amphetamine-induced changes in behavior and caudate extracellular acetylcholine
Florin, S. M., Kuczenski, R. T., & Segal, D. S. (1992) · Brain Research · doi:10.1016/0006-8993(92)90343-8 · Cited by 25
Self-citationKalisker, A., Waymire, J. C., & Rutledge, C. O. (1975) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30122-9 · Cited by 19
Research works printed but not linked: 1
- Cole SO (1978) Brain mechanisms ofamohetamine-induced anorexia. locomdtion, And stereotypy: a review. fieurosci Biobehav Rev 2:891 100.
Cited by
Sorted by citations
Berridge, C. W., & Waterhouse, B. D. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(03)00143-7 · Cited by 2,529
Vanderschuren, L. J. M. J., & Kalivas, P. W. (2000) · Psychopharmacology · doi:10.1007/s002130000493 · Cited by 1,360
Winstanley, C. A., Eagle, D. M., & Robbins, T. W. (2006) · Clinical Psychology Review · doi:10.1016/j.cpr.2006.01.001 · Cited by 893
Amphetamine, past and present – a pharmacological and clinical perspective
Heal, D. J., Smith, S. L., Gosden, J., & Nutt, D. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113482532 · Cited by 653
Neuroadaptations involved in amphetamine and cocaine addiction
White, F. J., & Kalivas, P. W. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00072-6 · Cited by 513
Metadata
- Authors
- Kuczenski, R., Segal, D., Cho, A., & Melega, W.
- Affiliations
- UC San Diego Health System (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 1995-02-01
- Volume
- 15
- Issue
- 2
- Pages
- 1308-1317
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6577819
- OpenAlex
- W1934404972
- Cited by
- 376
- References
- 44
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 11 · 2022: 10 · 2021: 13 · 2020: 6 · 2019: 5 · 2018: 5 · 2017: 11 · 2016: 9 · 2015: 9 · 2014: 24 · 2013: 18 · 2012: 22
- FWCI
- 3.33
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01da002411-13, 5r01da004157-14)
- U.S. Public Health Service
- National Institute on Drug Abuse (DA-01568, DA 02411, DA04157, R01DA001568)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- methamphetamine, d-amphetamine, stereotypy, dopamine release, noradrenaline release, serotonin release, caudate nucleus, hippocampus, vesicular transporters, structure-activity relationship, microdialysis
- MeSH terms
- Amphetamine, Animals, Behavior, Animal, Caudate Nucleus, Dopamine, Hippocampus, Methamphetamine, Norepinephrine, Serotonin, Stereoisomerism, Stereotyped Behavior, Microdialysis, Neurotransmitter Agents, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
